biotech fireworks | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical biotech fireworks

Previous 10 Next 10

To: scaram(o)uche who wrote (2571)	7/25/2006 2:16:07 PM
From: dr.praveen	of 7424

Give me a chance :-) n I will try

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: tuck who wrote (2572)	7/25/2006 3:34:34 PM
From: idos	of 7424

I still think that ENCY will beat MYOG to the market.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: idos who wrote (2576)	7/25/2006 3:58:50 PM
From: tuck	of 7424

>>I still think that ENCY will beat MYOG to the market.<< So do I, though my confidence in that belief is a tad shaken. At least they beat MYOG in Europe. Nor do I think MYOG has a clinically relevant advantage in their drug. At least, I won't think so until liver enzyme data beyond 12 weeks is shown to me and proves me wrong (in case you haven't followed this issue, it's at 18 weeks that these levels tend to get elevated for patients on this class of drug). They claim they have patients with benign liver enzymes for two years, but they won't show anyone the data. I won't say more about that here; it's been hashed out on the company specific threads. Cheers, Tuck

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: tuck who wrote (2577)	7/25/2006 5:44:58 PM
From: idos	of 7424

I have been following for the past 8 months but bought ENCY just today after the fall.I think that the FDA will approve Thelin, it is only a question of time and money which i hope will not be long&dear. Good day to you and sweet dreams for me. Ido

Share	RecommendKeepReply Mark as Last Read

From: tom pope	7/26/2006 9:12:28 AM
	of 7424

DOVP: SOMERSET, N.J., July 26 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. (Nasdaq: DOVP - News) announced today the completed assessment of results from the carcinogenicity studies for its novel analgesic, bicifadine. There were no meaningful signals of carcinogenicity detected after two years of testing in two species -- rats and mice. The Company believes these results are very positive, as this outcome from these two important safety studies will support the ability of DOV to file an NDA with the U.S. Food and Drug Administration (FDA) and other regulatory agencies worldwide.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: tom pope who wrote (2579)	7/26/2006 9:15:14 AM
From: Robohogs	of 7424

25% on safety studies for a failed efficacy drug? Jon

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Robohogs who wrote (2580)	7/26/2006 9:21:45 AM
From: tom pope	of 7424

It's coming back to earth, now up just under 15%

Share	RecommendKeepReply Mark as Last Read

To: dr.praveen who wrote (2575)	7/26/2006 8:33:54 PM
From: zeta1961	of 7424

You're too, too cute Doc P..I just people marked ya!° Ineterrrrrresting...I came from 'vacay' and had about 3 more people marks and 3 more ignores-g-...not to diminish..but I´'ve alwayys<<<<<<<<<<<<<<<<<since Yahoo have wondered/doubted this 'recommended' post business...just like you recentlz earned it...the best rec's come when the check book is content-g- May yóur portfolio grow and grow! Elisabeth

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: zeta1961 who wrote (2582)	7/27/2006 4:11:09 PM
From: tuck	of 7424

BIOV -- Bioveris, or what's left of the old IGEN -- up 20% on getting a CRO to sell their stuff: Message 22663106 There have also been rumors Roche Diagnostics is selling in Bioveris' field, just like it did with IGEN. If so, that'll get them into arbitration, and odds are it would be favorable to BIOV. But so far, I've heard only rumors, based on some language in their 10-K, I think. Cheers, Tuck

Share	RecommendKeepReply Mark as Last Read

From: JMarcus	7/27/2006 5:05:29 PM
	of 7424

Valentis (VLTS) up 55% today on heavy volume. Anyone know why? I didn't see any news posted on Yahoo. Even after today's fireworks, the stock only commands a price of 62 cents per share. Marc

Share	RecommendKeepReply Mark as Last Read